Tiny particles released by most human cells may be promising targets for diagnosis and treatment of an array of diseases from cancer to Alzheimer's, but scientists have struggled to see them and study ...
Choosing the Right Cell Scraper: Stellar Scientific Outlines Key Features for Tissue Culture Success
"cell scrapper"Stellar Scientific outlines crucial design specifications and material selections for cell scrapers to ...
Huntingdon-based Goodfellow, one of the UK’s leading suppliers of advanced metals and materials, is looking to build on strong double-digit international growth when it heads to the Advanced Materials ...
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second ...
Oxford Technology has made an undisclosed investment in Accelerated Diagnostics, which is developing ultra-rapid diagnostic technology capable of identifying infectious diseases on farms in as little ...
AnteoTech has expanded its high-tech battery materials line-up with the launch of Anteo C and has shipped a 20L sample to ...
Overview: We built this list around a documented selection process, not personal taste, weighing factors such as authority, teaching quality, and how well each ...
Baird initiates Abbott Labs as outperform Baird says the company has a robust portfolio. "Despite near-term pressures, we see ...
While public conversations may often focus on chatbots and workplace automation, To sees specialized AI systems trained on ...
Interesting Engineering on MSN
New 3D-printed electrolyte tech lets engineers create batteries in almost any shape
Researchers at the University of Texas at El Paso (UTEP) have created a 3D ...
Discover how AI is transforming healthcare while keeping human clinicians at the centre of care, ensuring safer, more personalised and patient-focused treatment.
NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical-stage regenerative medicine company developing stem-cell-derived therapies, announced the successful completion of its Type B Pre-IND meeting with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results